A 10-minute test has been developed to detect the Ebola virus in humans Researchers from the Massachusetts Institute of Technology have developed an easy-to-use test that can quickly determine whether a patient has dangerous diseases, including the deadly Ebola virus, which has been raging in several African countries for several months. Ebola has killed more than 9,600 people to date, and the number of victims of the virus will only increase in the future, since no effective means of combating it has yet been found. The uniqueness of the test lies in its compactness and high speed of obtaining analysis results. The test takes only 10 minutes to complete, which is significantly less than other test options. Such efficiency can be an important step in the fight against the spread of the virus, because it is important not only to be able to cure it, but also to find out as quickly as possible whether a person is a carrier of a fatal disease or not. All existing methods to detect the presence of the Ebola virus in human blood require sending a blood sample to a laboratory, and researchers will only receive the result after several days of painstaking work. During this time, the patient may have time to infect several other people. That's why speeding up the test result was key for the MIT researchers. The test is a paper strip developed using Lateral Flow technology, which is somewhat reminiscent of a pregnancy test, with the only difference being that the patient’s blood is used as the test material. Imagine that doctors in the field in third world countries have neither electricity nor expensive laboratory equipment at hand to carry out tests - such tests will be simply worth their weight in gold for them. Of course, Lateral Flow technology was further developed by scientists using their own inventions. For example, the test used a multiplexing technique, when one test strip can simultaneously detect several different diseases in a patient, thanks to multi-colored nanoparticles applied to it. Currently, the rapid test is able to detect the presence of Ebola fever, Dengue fever and yellow fever (amaryllosis) in people. All of these fevers are most common in African countries, so the test will greatly simplify the lives of volunteers who risk their lives every day in the fight against deadly diseases in third world countries. In the very near future, the creators of the test plan to submit it to the American FDA commission, which will make the final decision: to allow or prohibit the use of this technique in field conditions. If you've read the article this far please like and subscribe - it really helps the channel. Open the link to find thousands of interesting articles: https://wwww.youtube.com/...ity/yyt3.ggpht.com/...-v1